Dendrimer-Conjugated nSMase2 Inhibitor Reduces Tau Propagation in Mice is a research paper published in Pharmaceutics (2022). On theSindex it has a DataRank of 0. It has been cited 27 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Health
Grant: R01 AG063831
National Institute of Health
Grant: R01 AG059799
National Institute of Health
Grant: P30 MH075673
National Institute of Health
Grant: T-PEP-18-579974C
National Institute of Health
Grant: 135726
National Institute of Health
Grant: NIH R25GM109441
NIH HHS
Grant: R25 GM109441
National Institutes of Health
Grant: 5R25GM109441-05
HopkinsPREP: Research, Community, Professional Training and Personal Growth
National Institutes of Health
Grant: 5R01AG063831-02
Dendrimer-conjugated nSMase2 inhibitor as a novel therapeutic approach for Alzheimer's Disease
National Institutes of Health
Grant: 2P30MH075673-11A1
JHU NIMH Center for Novel Therapeutics for HIV-associated Cognitive Disorders
National Institutes of Health
Grant: 5R01AG059799-02
Regulation of Exosome Secretion as a novel therapeutic approach for Alzheimer's Disease
FWCI
1.80
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model
Additional file 1 of Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer’s disease mouse model